Skip to main content
14 December 2024
Last updated:
Monday 9 December 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
A new cell therapy approach to Alzheimer's disease
Read more
Strengths and shortcomings of new EU rules for ATMPs
Read more
Direct cell reprogramming: Mogrify and Astellas to address hearing loss
Read more
A cell therapy approach for hearing loss
Read more
Cell Therapy: TreeFrog Therapeutics on the go
Read more
A record year for the financing of ATMPs
Read more
Top 10 financing events for ATMPs in 2020
Read more
Integrated product development for ATMPs
Read more
The role of base and prime editing in therapeutics
Read more
Gene-edited therapies produce first clinical data
Read more
Pagination
Current page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form